Search results
Senior Advisor. ANDREW "DREW" E. SENYEI, M.D., has more than 25 years of experience in the building of emerging, life science and healthcare companies. Dr. Senyei has served on the Boards of more than 30 private and public companies.
Apr 2, 2020 · Andrew “Drew” Senyei, MD, is a medical doctor who has spent much of his life starting and growing biotechnology companies. He spent 25 years as managing director of Enterprise Partners Venture Capital and was the founding investor in Nuvasive, a non-invasive orthopedic company.
ANDREW (“Drew”) SENYEI, M.D., is a venture capitalist and inventor with more than 30 years of experience in the building of emerging technology and healthcare companies. For 25 years, he served as managing director of Enterprise Partners Venture Capital, which has $1.1 billion under management.
Information on valuation, funding, cap tables, investors, and executives for NoniGenex. Use the PitchBook Platform to explore the full profile.
Andrew ("Drew") Senyei, M.D., is a physician, venture capitalist, and inventor with more than 30 years of experience in the building of emerging technology and healthcare companies. Dr. Dr. Senyei served as Managing Director of Enterprise Partners Venture Capital for more than 25 years with $1.1B under management.
Jul 24, 2018 · Andrew (“Drew”) Senyei, M.D. Chairman, NeoSeq Ltd. He was managing director of Enterprise Partners Venture Capital for 25 years and has served on the boards of more than 35 private and public companies.
Andrew (“Drew”) E. Senyei, M.D. is a physician, venture capitalist, and inventor with more than 30 years of experience in the building of emerging technology and healthcare companies. He served as Managing Director of Enterprise Partners Venture Capital for more than 25 years with U.S.$1.1 billion under management.
